COLLEEN BARTHOLOMEW: Open Payments
NPI 1558923680 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,328 in 36 payments from 20 companies in 2025. Trend: 2023 $2,849 · 2024 $2,210 · 2025 $2,328
Consulting: $1,452Food & beverage: $856Education: $20
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 11 | $1,752 |
| Eisai Inc. | 1 | $120 |
| Janssen Scientific Affairs, LLC | 1 | $110 |
| Janssen Biotech, Inc. | 5 | $54 |
| PFIZER INC. | 2 | $29 |
| E.R. Squibb & Sons, L.L.C. | 2 | $28 |
| ABBVIE INC. | 1 | $27 |
| Genentech USA, Inc. | 1 | $21 |
| Aveo Pharmaceuticals, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
Products named: DATROWAY, Enhertu, Lenvima, ERLEADA, OPDUALAG, EPKINLY, RYBREVANT, DARZALEX.
Industry payments across NE — which companies pay providers there.
